A Czech pharmaceutical company has succeeded in attracting an investor despite world financial crisis which has been hampering most business. The Japanese company Foji Capital has bought 49.8% of I.Q.A. shares. It also pledged to finance other projects of this developmental laboratory. Foji Capital will thus spend tens of millions of dollars in the Czech Republic altogether. Twenty million for projects I.Q.A. develops pharmaceutical products for the treatment of cancer or HIV, but it also owns a patent on dexibuprofen, which releases the effective substance much faster than its ordinary version. “We can sell our patent in the form of licences, but we are considering our own production,” Xenie Svobodová, I.Q.A. board chairwoman, says by way of explanation as toContinue Reading